Non-Prescription Medications That Are Safe to Take During Pregnancy

Total Page：16

File Type：pdf, Size：1020Kb

Non-prescription Medications That Are Safe To Take During Pregnancy We want to help make your pregnancy a healthy, happy experience. There may be times throughout your pregnancy when you may feel the need to take over-the-counter medication for everyday illnesses. The following list of over-the-counter medications is considered safe for pregnant women. Please follow the instructions on the package for appropriate dose. CONDITION MEDICATIONS Cold or Plain Robitussin cough syrup (Guaifenesin), all cough drops, sore throat Chloraseptic Sore Throat Spray (Phenol) Cold, sinus Actifed (Phenylephrine), Chlor-Trimeton (Chlorpheniramine), congestion, Claritin (Loratadine), Zyrtec (Cetirizine) or saline nasal spray. allergies Sudafed (Pseudoephedrine) can be used in the second and third trimesters. Constipation Pericolace (Sennosides/Docusate), Colace (Docusate), Metamucil (Psyllium), Fibercon (Polycarbophil), Milk of Magnesia (magnesium hydroxide), MiraLAX Diarrhea Immodium (Loperamide) Headache Plain Tylenol, Extra Strength Tylenol (acetaminophen) Heartburn Tums, Maalox, Mylanta, Rolaids, Gaviscon (Calcium or indigestion Carbonate) Pepcid AC (Famotidine), Zantac (Ranitidine), Axid AR (Nizatidine) Hemorrhoids Preparation H (Phenylephrine/Hydrocortisone) cream, ointment, gel, pads or suppositories, Anusol (Hydrocortisone); Tucks pads (Witch hazel); Americaine (Benzocaine); non-medicated sitz baths Insomnia Benadryl (Diphenhydramine), Unisom (Doxylamine), Tylenol PM Nausea Ginger lollipops, Vitamin B6 25-50 mg three times daily, Unisom (Doxylamine) ½ tablet twice daily, Benadryl (Diphenhydramine) Vaginal Itching Monistat 7 (Miconazole) UW Health Ob-Gyn Clinics 20 S. Park St. Clinic* Union Corners Clinic* 20 S. Park St., Suite 307 2402 Winnebago St. 20 S. Park St., Suite 506 Madison, WI 53704 Madison, WI 53715 (608) 242-6840 (608) 287-2830 West Clinic* Arboretum Ob-Gyn Resident 451 Junction Rd. Physician Clinic Madison, WI 53717 1102 S. Park St. (608) 265-7601 Madison, WI 53715 (608) 287-5898 *Location includes Midwifery Clinic For a complete list of our providers and clinics, please visit uwhealth.org. OB-460767-20.

Copy Link

Recommended publications

The National Drugs List
^ ^ ^ ^ ^[ ^ The National Drugs List Of Syrian Arab Republic Sexth Edition 2006 ! " # "$ % &'() " # * +$, -. / & 0 /+12 3 4" 5 "$ . "$ 67"5,) 0 " /! !2 4? @ % 88 9 3: " # "$ ;+<=2 – G# H H2 I) – 6( – 65 : A B C "5 : , D )* . J!* HK"3 H"$ T ) 4 B K<) +$ LMA N O 3 4P<B &Q / RS ) H< C4VH /430 / 1988 V W* < C A GQ ") 4V / 1000 / C4VH /820 / 2001 V XX K<# C ,V /500 / 1992 V "!X V /946 / 2004 V Z < C V /914 / 2003 V ) < ] +$, [2 / ,) @# @ S%Q2 J"= [ &<\ @ +$ LMA 1 O \ . S X '( ^ & M_ `AB @ &' 3 4" + @ V= 4 )\ " : N " # "$ 6 ) G" 3Q + a C G /<"B d3: C K7 e , fM 4 Q b"$ " < $\ c"7: 5) G . HHH3Q J # Hg ' V"h 6< G* H5 !" # $%" & $' ,* ( )* + 2 ا اوا ادو +% 5 j 2 i1 6 B J' 6<X " 6"[ i2 "$ "< * i3 10 6 i4 11 6! ^ i5 13 6<X "!# * i6 15 7 G!, 6 - k 24"$d dl ?K V *4V h 63[46 ' i8 19 Adl 20 "( 2 i9 20 G Q) 6 i10 20 a 6 m[, 6 i11 21 ?K V $n i12 21 "% * i13 23 b+ 6 i14 23 oe C * i15 24 !, 2 6\ i16 25 C V pq * i17 26 ( S 6) 1, ++ &"r i19 3 +% 27 G 6 ""% i19 28 ^ Ks 2 i20 31 % Ks 2 i21 32 s * i22 35 " " * i23 37 "$ * i24 38 6" i25 39 V t h Gu* v!* 2 i26 39 ( 2 i27 40 B w< Ks 2 i28 40 d C &"r i29 42 "' 6 i30 42 " * i31 42 ":< * i32 5 ./ 0" -33 4 : ANAESTHETICS $ 1 2 -1 :GENERAL ANAESTHETICS AND OXYGEN 4 $1 2 2- ATRACURIUM BESYLATE DROPERIDOL ETHER FENTANYL HALOTHANE ISOFLURANE KETAMINE HCL NITROUS OXIDE OXYGEN PROPOFOL REMIFENTANIL SEVOFLURANE SUFENTANIL THIOPENTAL :LOCAL ANAESTHETICS !67$1 2 -5 AMYLEINE HCL=AMYLOCAINE ARTICAINE BENZOCAINE BUPIVACAINE CINCHOCAINE LIDOCAINE MEPIVACAINE OXETHAZAINE PRAMOXINE PRILOCAINE PREOPERATIVE MEDICATION & SEDATION FOR 9*: ;< " 2 -8 : : SHORT -TERM PROCEDURES ATROPINE DIAZEPAM INJ.
[Show full text]
Hygroscopicity of Pharmaceutical Crystals
HYGROSCOPICITY OF PHARMACEUTICAL CRYSTALS A DISSERTATION SUBMITTED TO THE FACULTY OF GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY DABING CHEN IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY RAJ SURYANARAYANAN (ADVISER) JANUARY, 2009 © Dabing Chen, January / 2009 ACKNOWLEDGEMENTS I am very grateful to my thesis advisor, Prof. Raj Suryanarayanan, for his constant guidance, support, and encouragement throughout my research. Without his help, the completion of this thesis would be impossible. His friendship and advices are precious to my professional and personal growth and will help me overcome many difficulties in my future career. I would like to take the opportunity to thank Prof. David J.W. Grant, who was my advisor during the first three years in graduate school and led me into the research area of physical pharmacy. It was my great honor to have worked for him, and he will always live as a role model in my life. Many thanks to Dr. Zheng Jane Li at Boehringer Ingelheim Pharmaceuticals (BI) for her invaluable advice as an industrial mentor and also for agreeing to serve on my committee. I sincerely appreciate her helpful discussions, revision of the manuscripts, and supervision of my research. I also want to thank her for providing me the internship opportunity at BI. I thank Dr. Timothy S. Wiedmann and Dr. Theodore P. Labuza for serving on my committee and for critically reviewing my thesis. I also want to thank Dr. Timothy S. Wiedmann for allowing me the use of the HPLC instruments in his lab and also for his advice as the Director of Graduate Studies.
[Show full text]
F 009 035 Benzocaine 20%, Lidocaine Hydrochoride 7
MEDISCA® NETWORK INC. TECHNICAL SUPPORT SERVICES FORMULATION CHEMISTRY DEPARTMENT TOLL-FREE: 866-333-7811 TELEPHONE: 514-905-5096 FAX: 514-905-5097 [email protected] 1/4/2021; Page 1 Suggested Benzocaine 20%, Lidocaine Hydrochloride 7%, Tetracaine Hydrochloride 7% FIN F 009 035 Formula Topical Gel (Suspension, 30 g) SUGGESTED FORMULATION Lot Expiry Ingredient Listing Qty. Unit NDC # Supplier Number Date Benzocaine, USP 6.000 g Lidocaine Hydrochloride, USP TBD Tetracaine Hydrochloride, USP 2.100 g Polysorbate 80, NF 0.5 mL Ethoxy Diglycol, NF 0.5 mL Medisca VersaPro™ Anhydrous Base 1.50 g Medisca VersaPro™ Anhydrous Base TBD MEDISCA® NETWORK INC. TECHNICAL SUPPORT SERVICES FORMULATION CHEMISTRY DEPARTMENT TOLL-FREE: 866-333-7811 TELEPHONE: 514-905-5096 FAX: 514-905-5097 [email protected] 1/4/2021; Page 2 Suggested Benzocaine 20%, Lidocaine Hydrochloride 7%, Tetracaine Hydrochloride 7% FIN F 009 035 Formula Topical Gel (Suspension, 30 g) SPECIAL PREPARATORY CONSIDERATIONS Ingredient-Specific Information Benzocaine, Tetracaine Hydrochloride, Polysorbate Light Sensitive (protect from light whenever possible): 80 Tetracaine Hydrochloride, Polysorbate 80, Ethoxy Hygroscopic (protect from moisture whenever possible): Diglycol Oxygen Sensitive (protect from air whenever possible): Polysorbate 80 Narrow Therapeutic Index Lidocaine Hydrochloride Suggested Preparatory Guidelines ■ Non-Sterile Preparation □ Sterile Preparation Processing Error / To account for processing error considerations during preparation, it is suggested to Testing Considerations: measure an additional 12 to 15% of the required quantities of ingredients. Special Instruction: This formula may contain one or more Active Pharmaceutical Ingredients (APIs) that may be classified as hazardous, please refer & verify the current NIOSH list of Antineoplastic and Other Hazardous Drugs in Healthcare Settings.
[Show full text]
Medication Other Information Aches and Pains Constipation Cough/Cold Diarrhea Fever Over the Counter Medications in Pregnancy
Over the Counter Medications in Pregnancy Women commonly use over the counter medications in pregnancy. This is a list of those medication you may safely use during pregnancy. If you have any questions about these medications and how to use them please contact your Healthcare Provider's office. Unless otherwise stated please take the medication as directed on the manufactures label. Medication Other Information Aches and Pains * Tylenol Extra Strength 500 mg tablet No more than 6 tablets in a 24 hour period * Tylenol 325 mg tablet No more than 8 in a 24 hour period Constipation Stool Softener Increases the amount of water in your stools to make them easier to pass * Colace (docusate sodium) * Surfak (docusate calcium) * Docusate Fiber Laxative Increases the amount of bulk in your stools to make them easier to pass * Metamucil (psyllium) * Fibercon (Calcium polycarbophil 625 mg) Stool Softener/Fiber Laxative Increases the amount of water in your stools to make them easier to pass * Peri-Colace (docusate sodium/sennosides) * Senekot -S (docusate sodium/sennosides) Osmotic Laxative Increases the amount of water in your stools to make them easier to pass * Milk of Magnesia * MiraLax (polyethylene glycol 3350) Cough/Cold Expectorants Help thin mucus and phlegm so they can be coughed up * Robitussin * Guaifenesin Antihistamines Can be used to relieve seasonal allergy and common cold symptoms of nasal congestion, * Chlorpheniramine sneezing and itchy eyes Cough Suppressants Help calm a cough * Dextromethorphan Decongestants Are used to relieve
[Show full text]
Notice Under S66 of the Commerce Act 1986 Application by Johnson & Johnson to Acquire the Stock, Assets and Business Of
PUBLIC COPY Notice under s66 of the Commerce Act 1986 Application by Johnson & Johnson to acquire the stock, assets and business of the Consumer Healthcare division of Pfizer Inc. COMMERCE ACT 1986: BUSINESS ACQUISITION SECTION 66: NOTICE SEEKING CLEARANCE 28 September 2006 The Registrar Business Acquisitions and Authorisations Commerce Commission PO Box 2351 Wellington Pursuant to s66(1) of the Commerce Act 1986 notice is hereby given seeking clearance of a proposed business acquisition. 518689_1.DOC 2 CONTENTS EXECUTIVE SUMMARY PART 1: TRANSACTION DETAILS 1 The business acquisition for which clearance is sought 2 The person giving this notice 3 Confidentiality 4 Participants 5 Interconnected and associated persons 6 Beneficial interests 7 Links between participants 8 Common directorships 9 Business activities of the participants 10 Reasons for the proposed acquisition PART II: IDENTIFICATION OF MARKETS AFFECTED 11 Horizontal aggregation 12 Differentiated product markets 13 Differentiated product markets 14 Vertical integration 15 Other business acquisitions PARTS III, IV AND V: CONSTRAINTS ON MARKET POWERS BY EXISTING AND POTENTIAL COMPETITION AND OTHER POTENTIAL CONSTRAINTS 16 Allergy medication 17 Products for the treatment of worms 18 Thrush treatment CERTIFICATE APPENDICES 1. Heartburn and indigestion remedies (MYLANTA and MOTILIUM) 2. Worm treatments (COMBANTRIN, VERMOX) 3. Cold, flu, nasal decongestant, cough relief and sort throat medications (CODRAL, SINUTAB, SUDAFED, BENADRYL, BRONDECON) 4. Allergy relief products (ACTIFED, SINUTAB, SUDAFED, VISINE, LIVOSTIN) 518689_1.DOC 3 5. Thrush treatments (DIFLUCAN ONE, DAKTARIN, DAKTAGOLD, NIZORAL, SPORANOX) 6. Shampoo (PREGAINE, ROGAINE, NEUTROGENA, JOHNSON’S BABY SHAMPOO) 7. Hand hygiene (PURELL and MICRO SHIELD) 8. Competitor worm treatment products 9. Multinational pharmaceutical businesses: GlaxoSmithKline, Douglas Pharmaceuticals, Alphapharm, Bayer Group 10.
[Show full text]
Adverse Effects of Medications on Oral Health
Adverse Effects of Medications on Oral Health Dr. James Krebs, BS Pharm, MS, PharmD Director of Experiential Education College of Pharmacy, University of New England Presented by: Rachel Foster PharmD Candidate, Class of 2014 University of New England October 2013 Objectives • Describe the pathophysiology of various medication-related oral reactions • Recognize the signs and symptoms associated with medication-related oral reactions • Identify the populations associated with various offending agents • Compare the treatment options for medication-related oral reactions Medication-related Oral Reactions • Stomatitis • Oral Candidiasis • Burning mouth • Gingival hyperplasia syndrome • Alterations in • Glossitis salivation • Erythema • Alterations in taste Multiforme • Halitosis • Oral pigmentation • Angioedema • Tooth discoloration • Black hairy tongue Medication-related Stomatitis • Clinical presentation – Aphthous-like ulcers, mucositis, fixed-drug eruption, lichen planus1,2 – Open sores in the mouth • Tongue, gum line, buccal membrane – Patient complaint of soreness or burning http://www.virtualmedicalcentre.com/diseases/oral-mucositis-om/92 0 http://www.virtualmedicalcentre.com/diseases/oral-mucositis-om/920 Medication-related Stomatitis • Offending agents1,2 Medication Indication Patient Population Aspirin •Heart health • >18 years old •Pain reliever • Cardiac patients NSAIDs (i.e. Ibuprofen, •Headache General population naproxen) •Pain reliever •Fever reducer Chemotherapy (i.e. •Breast cancer •Oncology patients methotrexate, 5FU, •Colon
[Show full text]
2020 Over the Counter (OTC) Benefit Quick Reference Guide
2020 Community Health Choice (HMO D-SNP) OVER-THE-COUNTER (OTC) BENEFIT QUICK REFERENCE GUIDE Texas: Austin, Brazoria, Chambers, Fort Bend, Galveston, Hardin, Harris, Jasper, Jefferson, Liberty, Matagorda, Montgomery, Newton, Orange, Polk, San Jacinto, Tyler, Walker, Waller, and Wharton CommunityHealthChoice.org/Medicare 833.276.8306 or 713.295.5007 (TTY 711) October 1 through March 31, 8:00 am to 8:00 pm, 7 days a week and April 1 through September 30, Monday through Friday, 8:00 am to 8:00 pm H9826_PH_10163_111919_C 2020 Community Health Choice (HMO D-SNP) OVER-THE-COUNTER (OTC) BENEFIT QUICK REFERENCE GUIDE Plan Service Area CommunityHealthChoice.org/Medicare 833.276.8306 or 713.295.5007 (TTY 711) October 1 through March 31, 8:00 am to 8:00 pm, 7 days a week and April 1 through September 30, Monday through Friday, 8:00 am to 8:00 pm H9826_PH_10163_111919_C Thank you for choosing to get your Medicare health care and your prescription drug coverage through our plan, Community Health Choice (HMO D-SNP). As a Community Health Choice member, How do I use the OTC benefit? Over-The-Counter (OTC) Benefits Over-The-Counter (OTC) you get a quarterly Over-the-Counter As a member of Community Health Choice, (OTC) benefit that allows you to purchase you may obtain qualified OTC products items such as cold and cough medicines, through any pharmacy. After you have vitamins, dental care items, pain relievers, purchased your OTC products, you will and much more. The information below need to submit copies of your itemized describes how to take advantage of this purchase receipts within 30 days after the benefit.
[Show full text]
Fenestrations Control Resting-State Block of a Voltage-Gated Sodium
Fenestrations control resting-state block of a voltage- gated sodium channel Tamer M. Gamal El-Dina,1, Michael J. Lenaeusa,b,1, Ning Zhenga,c,2,3, and William A. Catteralla,2,3 aDepartment of Pharmacology, University of Washington, Seattle, WA 98195; bDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA 98195; and cHoward Hughes Medical Institute, University of Washington, Seattle, WA 98195 Contributed by William A. Catterall, October 31, 2018 (sent for review September 4, 2018; reviewed by Ryan Hibbs, Michael C. Sanguinetti, and Joerg Striessnig) Potency of drug action is usually determined by binding to a specific Receptor Hypothesis posits that resting-state block is mediated receptor site on target proteins. In contrast to this conventional by drug entry from the lipid phase of the membrane into the drug paradigm, we show here that potency of local anesthetics (LAs) and receptor site in the pore, and rapid open-state block occurs as the antiarrhythmic drugs (AADs) that block sodium channels is con- drug enters the open pore from the cytoplasm (15). Both of these trolled by fenestrations that allow drug access to the receptor site forms of block are enhanced when the channel enters the inac- directly from the membrane phase. Voltage-gated sodium channels tivated state, which has high affinity for bound drug (15). It is initiate action potentials in nerve and cardiac muscle, where their well-established that LAs and AADs can reach their binding site hyperactivity causes pain and cardiac arrhythmia, respectively. LAs from the intracellular side if the activation gate is open, which and AADs selectively block sodium channels in rapidly firing nerve gives open-state block, and that inactivation increases the affinity and muscle cells to relieve these conditions.
[Show full text]
Medication Guide for a Safe Recovery
Medication Guide For A Safe Recovery A guide to maintaining sobriety while receiving treatment for other health problems. Revision 1.0 -April 2008 Table of Contents Introduction..................................................................................2 How to Use this Guide..................................................................3 Class A Drugs (Absolutely Avoid)................................................4 Class B Drugs................................................................................8 (With Addiction Medicine Specialist/Doctor Approval Only) Class C Drugs (Generally Safe to Take).....................................12 Alcohol-Free Products..................................................................16 Incidental Exposure Index...........................................................22 www.talbottcampus.com Introduction From the Talbott Recovery Campus Welcome to the Talbott Recovery Campus guide for a safe and sustained recovery. This document was developed through a collaborative effort between some of the best minds in addiction care today and will help you make wise decisions, ensuring that medications you may be prescribed and incidental exposure to alcohol do not threaten your hard won recovery. This guide is divided into three sections and is based on the drug classification system developed nearly 20 years ago by Dr. Paul Earley and recently expanded on by Bruce Merkin, M.D., Renee Enstrom, Nicholas Link and the staff at Glenbeigh hospital. Part one provides a way of categorizing medications
[Show full text]
Pharmaceuticals As Environmental Contaminants
PharmaceuticalsPharmaceuticals asas EnvironmentalEnvironmental Contaminants:Contaminants: anan OverviewOverview ofof thethe ScienceScience Christian G. Daughton, Ph.D. Chief, Environmental Chemistry Branch Environmental Sciences Division National Exposure Research Laboratory Office of Research and Development Environmental Protection Agency Las Vegas, Nevada 89119 [email protected] Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Why and how do drugs contaminate the environment? What might it all mean? How do we prevent it? Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada This talk presents only a cursory overview of some of the many science issues surrounding the topic of pharmaceuticals as environmental contaminants Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada A Clarification We sometimes loosely (but incorrectly) refer to drugs, medicines, medications, or pharmaceuticals as being the substances that contaminant the environment. The actual environmental contaminants, however, are the active pharmaceutical ingredients – APIs. These terms are all often used interchangeably Office of Research and Development National Exposure Research Laboratory, Environmental Sciences Division, Las Vegas, Nevada Office of Research and Development Available: http://www.epa.gov/nerlesd1/chemistry/pharma/image/drawing.pdfNational
[Show full text]
SAFE OVER-THE-COUNTER MEDICATIONS, ACCEPTABLE ANTIBIOTICS and MEDICATIONS to AVOID for KIDNEY, and PANCREAS TRANPLANT PATIENTS Updated February 2014
SAFE OVER-THE-COUNTER MEDICATIONS, ACCEPTABLE ANTIBIOTICS AND MEDICATIONS TO AVOID FOR KIDNEY, AND PANCREAS TRANPLANT PATIENTS Updated February 2014 What are the concerns with over the counter medications use after transplant? Some non-prescription or over-the-counter medications may interact with your transplant medications, raise your blood pressure and heart rate, or affect how well your transplant is working. For example, non-steroidal anti- inflammatory (NSAID) medications such as ibuprofen (Advil® or Motrin® for example) can worsen your renal function and should be avoided after transplant. Products that contain decongestants such as pseudoephedrine (Sudafed® for example) can increase your heart rate, blood pressure and worsen your renal function and should also be avoided after transplant. How do I know if an over the counter medication is safe to take? On the second page of this document, we have a list of medications that are safe for you to take after transplant. Most medications have several names. The best place to look for the generic name is on the back of the package under “Ingredients”. Be sure to read the labels of all medications. Single active ingredient products are better choices than products with more than one active ingredient, as they may contain ingredients that are unsafe for you to take after transplant. For example, Tylenol® (acetaminophen) is ok to take after transplant, but Tylenol® Cold Head Congestion Daytime contains acetaminophen, dextromethorphan and phenylephrine. Because this product contains a decongestant (phenylephrine), it should NOT be used by transplant patients. Phenylephrine can increase blood pressure and heart rate and affect how well the transplant organ is working.
[Show full text]
The Effectiveness of Ketamine As an Anesthetic for Fish (Rainbow Trout – Oncorhynchus Mykiss)
Research Article Oceanogr Fish Open Access J Volume 13 Issue 1 - January 2021 Copyright © All rights are reserved by Mohammedsaeed Ganjoor DOI: 10.19080/OFOAJ.2021.13.555852 The Effectiveness of Ketamine as an Anesthetic for Fish (Rainbow Trout – Oncorhynchus mykiss) Mohammedsaeed Ganjoor*, Maysam Salahi-ardekani, Sajad Nazari, Javad Mahdavi, Esmail Kazemi and Mohsen Mohammadpour Genetic and Breeding Research Centre for Cold Water Fishes (ShahidMotahary Cold-water Fishes Center), Iranian Fisheries Science Research Institute, Iran Submission: November 03, 2020; Published: January 12, 2021 Corresponding author: Mohammedsaeed Ganjoor, Genetic and Breeding Research Centre for Cold Water Fishes (ShahidMotahary Cold-water Fishes Center), Iranian Fisheries Science Research Institute, Agricultural Research Education and Extension Organization (AREEO), Yasuj, IRAN Email: [email protected] & [email protected] Abstract Ketamine was evaluated as water-soluble anesthetics drug for a species of fish, rainbow trout (Oncorhynchus mykiss). Fish (size ~20 - ~240 anesthesiagr.) were exposed duration to (stage1 a 100-ppm to 3) concentrationand recovery duration of Ketamine was recorded.solution (dissolved Also, surveillance in water), was they evaluated were arranged after recovery. in 4 treatments Ketamine wasbased effective on their to weight range (Treatment-1= 22.8±3.4 g; Treatment-2= 51.7±4.4 g; Treatment-3= 69.8±5.2 g and Treatment-4= 243.8±20.7 g). Elapsed time for cause anesthesia in the fish as 100 ppm concentration. 10 fishes of each treatment (%100) were anesthetized and were induced in stageIII-Plane3 of anesthesia within 2-3 min after exposure to anesthetic solution (Treatment-1= 110.3±3.5 seconds; Treatment-2= 140.0±5.9 sec; Treatment-3= 180.0±5.8 sec and Treatment-4= 190.0±5.8 sec).
[Show full text]